Dupuytren’s disease cords are weakened ex vivo by injection of recombinant collagenase G – A proof-of-concept study
Guy Rubin, David Rothem, Ran Tohar, Maayan Gal · 2026
Read Dupuytren’s disease cords are weakened ex vivo by injection of recombinant collagenase G – A proof-of-concept study by Guy Rubin, David Rothem, Ran Tohar, Maayan Gal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359330.txt.
Description
Guy Rubin and three colleagues report a small laboratory test of a new enzyme treatment for Dupuytren's disease, published in PLOS ONE in 2026. The disease builds collagen rich cords in the hand that slowly pull fingers into a bent position. An injected bacteria made collagenase already treats it without surgery, and the team asked whether a lab made version of a related enzyme could do the same job.
They took cords removed during surgery from five patients, injected the test enzyme or a plain buffer, and pulled the tissue apart on a measuring machine. Enzyme treated cords tore under clearly less force, roughly a third lower in this tiny series. The authors call it early proof of concept and say dose, timing, and safety work must come before any patient use.
Catalog record
| CREATOR | Guy Rubin, David Rothem, Ran Tohar, Maayan Gal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18301 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |